Entrada Therapeutics, Inc. TRDA

Full chart Compare
Set alert

Price alert · TRDA

All alert types
4.55 USD -0.51 (-10.08%)

At closeNov 5, 2026, 4:29 PM EST

4.56 +0.01 +0.24%

After hours · Nov 5, 4:29 PM ET

4.52 Day range 5.07
4.11 52-week range 16.45
YTD
-55.74%
1 year
-34.44%

Revenue & Expenses

Other Income → Expenses: $15.07MExpenses → Selling, General & Admin: $41.05MExpenses → Research & Development: $142.27MExpenses → Income Tax: $924.00KGross Profit → Expenses: $25.42MRevenue → Gross Profit: $25.42MNet Loss → Expenses: $143.75MOther Income$15.07MGross Profit$25.42MNet Loss$143.75MExpenses$184.24MSelling, General & Admin$41.05MResearch & Development$142.27MIncome Tax$924.00KRevenue$25.42M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

TRDA annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
25.42M210.78M129.01M00
25.42M210.78M129.01M00
25.42M210.78M129.01M00
183.32M163.77M132.18M97.25M51.13M
142.27M125.31M99.88M66.61M35.93M
41.05M38.47M32.29M30.64M15.20M
-157.90M47.01M-3.16M-97.25M-51.13M
924.00K859.00K18.74M00
-143.75M65.63M-6.68M-94.62M-51.16M
-143.75M65.63M-6.68M-94.62M-51.16M
-143.75M65.63M-6.68M-94.62M-51.16M
-143.75M65.63M-6.68M-94.62M-51.16M
-3.471.76-0.20-3.02-8.16
-3.471.76-0.20-3.02-8.16
-3.471.68-0.20-3.02-8.16
-142.83M66.48M12.06M-94.62M-51.19M
-142.83M66.48M12.06M-94.62M-51.19M
41.37M37.31M33.05M31.29M6.27M
41.37M39.00M33.05M31.29M6.27M